Cargando…

Biochemical diagnosis of Sanfilippo disorder types A and B

BACKGROUND: One of the 11 recognized mucopolysaccharidosis (MPS) diseases is Sanfilippo. It is autosomal recessive in its mode of transmission. There are four subtypes of Sanfilippo (A, B, C, and D). The most worldwide prevalent subtypes of mucopolysaccharidosis type III (MPS III) are A and B follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosier, Soha S., El Nakeeb, Seham M. S., Ibrahim, Mona M., El-Gammal, Mona, Fateen, Ekram M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638229/
https://www.ncbi.nlm.nih.gov/pubmed/37947910
http://dx.doi.org/10.1186/s43141-023-00586-7
_version_ 1785133559531438080
author Nosier, Soha S.
El Nakeeb, Seham M. S.
Ibrahim, Mona M.
El-Gammal, Mona
Fateen, Ekram M.
author_facet Nosier, Soha S.
El Nakeeb, Seham M. S.
Ibrahim, Mona M.
El-Gammal, Mona
Fateen, Ekram M.
author_sort Nosier, Soha S.
collection PubMed
description BACKGROUND: One of the 11 recognized mucopolysaccharidosis (MPS) diseases is Sanfilippo. It is autosomal recessive in its mode of transmission. There are four subtypes of Sanfilippo (A, B, C, and D). The most worldwide prevalent subtypes of mucopolysaccharidosis type III (MPS III) are A and B followed by C and D subtypes. To estimate the frequency of MPS IIIA among MPS III patients, we diagnose and compare their clinical features with those of MPS IIIB and also compare the prevalence of MPS IIIB versus MPS IIIA among diagnosed cases at the Biochemical Genetic Department at NRC. For every case that was referred, the quantitative determination of urine Glycosaminoglycans (GAGs) was assessed. Two-dimensional electrophoresis (2DE) of GAGs extracted from urine was performed on all cases with high urinary GAG levels. Both N-sulphoglucosamine sulphohydrolase (MPS IIIA) and N-alpha-acetylglucosaminidase (MPS IIIB) enzyme activity were determined fluorometrically. RESULTS: From November 2019 to May 2022, 535 cases were referred to the National Research Centre’s Biochemical Genetics Department. 233 (43%) MPS cases were diagnosed with high urinary GAG levels for their ages. 73 (31.3%) MPS III cases were diagnosed by 2DE out of the 233 MPS cases. Plasma N-alpha-acetylglucosaminidase enzyme assay was insufficient in 36 (49.3%) patients (Sanfilippo type B), while N-sulphoglucosamine sulphohydrolase enzyme activity was deficient in 15 (20.6%) patients. The other 22 (30.1%) patients are either Sanfilippo type C or D. CONCLUSION: N-sulphoglucosamine sulphohydrolase enzyme activity was measured for the first time in Egypt. Thirty-one percent of all diagnosed MPS cases during the last 3 years were MPS type III, making Sanfilippo the most common MPS type among the referred cases to our Biochemical Genetics Department. MPS IIIA accounts for 20.6% of MPSIII cases in this study. Still, MPS type IIIB is the commonest type among diagnosed patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-023-00586-7.
format Online
Article
Text
id pubmed-10638229
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106382292023-11-11 Biochemical diagnosis of Sanfilippo disorder types A and B Nosier, Soha S. El Nakeeb, Seham M. S. Ibrahim, Mona M. El-Gammal, Mona Fateen, Ekram M. J Genet Eng Biotechnol Research BACKGROUND: One of the 11 recognized mucopolysaccharidosis (MPS) diseases is Sanfilippo. It is autosomal recessive in its mode of transmission. There are four subtypes of Sanfilippo (A, B, C, and D). The most worldwide prevalent subtypes of mucopolysaccharidosis type III (MPS III) are A and B followed by C and D subtypes. To estimate the frequency of MPS IIIA among MPS III patients, we diagnose and compare their clinical features with those of MPS IIIB and also compare the prevalence of MPS IIIB versus MPS IIIA among diagnosed cases at the Biochemical Genetic Department at NRC. For every case that was referred, the quantitative determination of urine Glycosaminoglycans (GAGs) was assessed. Two-dimensional electrophoresis (2DE) of GAGs extracted from urine was performed on all cases with high urinary GAG levels. Both N-sulphoglucosamine sulphohydrolase (MPS IIIA) and N-alpha-acetylglucosaminidase (MPS IIIB) enzyme activity were determined fluorometrically. RESULTS: From November 2019 to May 2022, 535 cases were referred to the National Research Centre’s Biochemical Genetics Department. 233 (43%) MPS cases were diagnosed with high urinary GAG levels for their ages. 73 (31.3%) MPS III cases were diagnosed by 2DE out of the 233 MPS cases. Plasma N-alpha-acetylglucosaminidase enzyme assay was insufficient in 36 (49.3%) patients (Sanfilippo type B), while N-sulphoglucosamine sulphohydrolase enzyme activity was deficient in 15 (20.6%) patients. The other 22 (30.1%) patients are either Sanfilippo type C or D. CONCLUSION: N-sulphoglucosamine sulphohydrolase enzyme activity was measured for the first time in Egypt. Thirty-one percent of all diagnosed MPS cases during the last 3 years were MPS type III, making Sanfilippo the most common MPS type among the referred cases to our Biochemical Genetics Department. MPS IIIA accounts for 20.6% of MPSIII cases in this study. Still, MPS type IIIB is the commonest type among diagnosed patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-023-00586-7. Springer Berlin Heidelberg 2023-11-10 /pmc/articles/PMC10638229/ /pubmed/37947910 http://dx.doi.org/10.1186/s43141-023-00586-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Nosier, Soha S.
El Nakeeb, Seham M. S.
Ibrahim, Mona M.
El-Gammal, Mona
Fateen, Ekram M.
Biochemical diagnosis of Sanfilippo disorder types A and B
title Biochemical diagnosis of Sanfilippo disorder types A and B
title_full Biochemical diagnosis of Sanfilippo disorder types A and B
title_fullStr Biochemical diagnosis of Sanfilippo disorder types A and B
title_full_unstemmed Biochemical diagnosis of Sanfilippo disorder types A and B
title_short Biochemical diagnosis of Sanfilippo disorder types A and B
title_sort biochemical diagnosis of sanfilippo disorder types a and b
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638229/
https://www.ncbi.nlm.nih.gov/pubmed/37947910
http://dx.doi.org/10.1186/s43141-023-00586-7
work_keys_str_mv AT nosiersohas biochemicaldiagnosisofsanfilippodisordertypesaandb
AT elnakeebsehamms biochemicaldiagnosisofsanfilippodisordertypesaandb
AT ibrahimmonam biochemicaldiagnosisofsanfilippodisordertypesaandb
AT elgammalmona biochemicaldiagnosisofsanfilippodisordertypesaandb
AT fateenekramm biochemicaldiagnosisofsanfilippodisordertypesaandb